Cronos Group Inc vs Vanguard High Dividend Yield ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while Vanguard High Dividend Yield ETF trades at $158.37 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 85.4× Cronos Group Inc's market cap, and Cronos Group Inc is more actively traded (968,037 versus 908,176). Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Vanguard High Dividend Yield ETF for 138 Days on average.
| CRON | VYM | |
|---|---|---|
Market Cap | $1.18B | $100.80B |
Volume | 968,037 | 908,176 |
Sector | Health | — |
52-Week High | $3.55 | $167.03 |
52-Week Low | $2.30 | $137.47 |
Typical Hold Time | 22 Days | 138 Days |
Enterprise Value | $387.62M | — |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
VYM trades at $157.45, down 0.58% with a bearish technical signal. The ETF shows neutral oscillators but bearish moving averages, with support at $157 and resistance at $158. Recent news highlights VYM's consistent dividend yield of 2.42% but notes performance lag versus peers like SCHD and IDV, which have outperformed year-to-date.
VYM faces competition from higher-yielding alternatives and exhibits vulnerability to dividend cuts in its holdings. The ETF's broad diversification provides stability, but investors may seek better returns elsewhere. Key risks include sector concentration and interest rate sensitivity affecting dividend appeal.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →